Premium Nahrungsergänzungsmittel | artgerecht

Hepatopulmonary – Syndrome, Causes and Treatment

Hepatopulmonary syndrome is a serious complication of liver disease in which abnormal widening of lung blood vessels leads to low oxygen levels in the blood.

Regular tips about health Regular tips about health

Things worth knowing about "Hepatopulmonary"

Hepatopulmonary syndrome is a serious complication of liver disease in which abnormal widening of lung blood vessels leads to low oxygen levels in the blood.

What Does Hepatopulmonary Mean?

The term hepatopulmonary combines the Latin words hepar (liver) and pulmo (lung). It describes the interaction or joint involvement of the liver and lungs in a disease process. In clinical practice, the term is most commonly used in connection with hepatopulmonary syndrome (HPS) – a serious complication of advanced liver disease.

Definition of Hepatopulmonary Syndrome

Hepatopulmonary syndrome is a condition in which chronic liver disease or portal hypertension (elevated pressure in the portal vein) leads to abnormal widening of small blood vessels within the lungs. These so-called intrapulmonary vascular dilatations (IPVD) impair gas exchange and cause a drop in blood oxygen levels, resulting in hypoxemia.

Causes

Hepatopulmonary syndrome typically develops as a consequence of:

Liver cirrhosis – the most common underlying condition
Chronic hepatitis (e.g., hepatitis B or C)
Non-cirrhotic portal hypertension
Acute liver failure (less common)
Congenital liver diseases (e.g., biliary atresia in children)

Impaired liver function leads to increased release of vasoactive substances – most notably nitric oxide (NO) – which cause excessive dilation of the pulmonary capillaries and disrupt normal oxygen uptake.

Symptoms

The symptoms of hepatopulmonary syndrome often develop gradually and may initially be non-specific:

Dyspnea (shortness of breath), especially during physical exertion
Platypnea – worsening breathlessness when standing upright, relief when lying down (a hallmark feature)
Orthodeoxia – a drop in oxygen saturation when moving from lying to standing
Cyanosis (bluish discoloration of lips and fingernails)
Clubbing of fingers and toes
General signs of liver disease: jaundice, ascites, spider angiomas

Diagnosis

Diagnosis of hepatopulmonary syndrome is based on a combination of findings:

Arterial blood gas analysis: Confirms hypoxemia (reduced partial pressure of oxygen, PaO2 < 80 mmHg)
Contrast echocardiography: Detects intrapulmonary shunts using agitated saline bubble study
Tc-99m MAA lung perfusion scan: Quantifies the extent of intrapulmonary shunting
Pulmonary function tests and high-resolution CT of the chest
Laboratory tests to assess liver function (Child-Pugh score, MELD score)

Treatment

To date, there is no approved medication that cures hepatopulmonary syndrome. The only potentially curative treatment is:

Liver transplantation: This is considered the treatment of choice and leads to complete or significant resolution of pulmonary changes in most patients. Patients with severe HPS receive priority points (MELD exception points) for organ allocation.

Supportive measures include:

Long-term supplemental oxygen therapy to relieve hypoxemia
Treatment of the underlying liver disease (e.g., antiviral therapy for hepatitis)
In selected cases: Transjugular intrahepatic portosystemic shunt (TIPS) or experimental therapies – evidence remains limited

Prognosis

Without treatment, the prognosis of hepatopulmonary syndrome is poor. The severity of hypoxemia correlates with mortality. Following successful liver transplantation, most patients recover well, although normalization of lung function may take several months.

References

European Association for the Study of the Liver (EASL): Clinical Practice Guidelines on the management of hepatic encephalopathy and hepatopulmonary syndrome. Journal of Hepatology, 2022.
Rodríguez-Roisin R, Krowka MJ: Hepatopulmonary Syndrome – A Liver-Induced Lung Vascular Disorder. New England Journal of Medicine, 2008; 358(22): 2378-2387.
Krowka MJ et al.: Hepatopulmonary Syndrome and Portopulmonary Hypertension: A Report of the Multicenter Liver Transplant Database. Liver Transplantation, 2004; 10(2): 174-182.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.